- Home »
- Quarterly Results »
- Amerise Biosciences Q1 Results Significant Loss of ₹4.87 Lakhs and Flat Revenue at ₹3.58 Lakhs
Amerise Biosciences Q1 Results Significant Loss of ₹4.87 Lakhs and Flat Revenue at ₹3.58 Lakhs
Amerise Biosciences Q1 Results showed a 348% YoY decline in net profit, from ₹1.96 lakhs to a loss of ₹4.87 lakhs, with flat QoQ revenue at ₹3.58 lakhs. Amerise Biosciences Q1 Results also revealed a 200% YoY increase in total expenses.
by Madhumitha
Updated Sep 05, 2024
Table of Content
Amerise Biosciences Q1 Results 2024-2025: Amerise Biosciences announced their financial results for the first quarter of 2024-2025 on 6 August 2024, showcasing a challenging period for the company. The unaudited financial results reveal a significant decline in revenue, with a year-over-year (YoY) decrease of 30.12%.
This drop reflects the ongoing difficulties the company has faced, including a continued scarcity of working capital and sluggish market conditions. The company's net profit for the quarter ended 30 June 2024 was a loss of ₹4.87 lakhs, showing a YoY shift from a profit of ₹1.96 lakhs reported for the same quarter last year.
In terms of quarterly performance, the revenue from operations remained flat at ₹3.58 lakhs, marking a 0% increase compared to the previous quarter, which ended on 31 March 2024.
Other expenses rose by 46.88% QoQ, further impacting the financial results. The overall expenses also increased by 200% YoY, contributing to the company's loss for the quarter. Despite these challenges, the company continues to navigate the tough market conditions as it works towards stabilizing its financial standing.
For More Q1 results check our Twitter Page.
Amerise Biosciences Q1 Results 2024-2025
Here is a summary of Amerise Biosciences' financial performance for the first quarter of 2024-2025:
| Particulars | Quarter Ended 30 June 2024 | Quarter Ended 31 March 2024 |
|---|---|---|
| Gross Revenue from the Sale of Products | ₹3.58 lakhs | ₹3.58 lakhs |
| Total Income | ₹3.58 lakhs | ₹3.58 lakhs |
| Employee Benefit Expense | ₹0.60 lakhs | ₹1.29 lakhs |
| Finance Costs | ₹0.33 lakhs | ₹0.33 lakhs |
| Other Expenses | ₹4.27 lakhs | ₹0.33 lakhs |
| Total Expenses | ₹4.87 lakhs | ₹1.62 lakhs |
| Profit/(Loss) from Operations | ₹(4.87) lakhs | ₹1.96 lakhs |
| Profit/(Loss) Before Tax | ₹(4.87) lakhs | ₹1.96 lakhs |
| Net Profit/(Loss) After Tax | ₹(4.87) lakhs | ₹1.96 lakhs |
| Total Comprehensive Income | ₹(4.87) lakhs | ₹1.96 lakhs |
| Paid-up Equity Share Capital | ₹660.69 lakhs | ₹660.69 lakhs |
| Other Equity | ₹660.69 lakhs | ₹660.69 lakhs |
| Basic Earnings Per Share | ₹(0.01) | ₹0.00 |
| Diluted Earnings Per Share | ₹(0.01) | ₹0.00 |
Source: Click Here
Amerise Biosciences Current Market Overview
Amerise Biosciences is currently trading at ₹0.83 per share, with a market capitalization of ₹5.48 crore. As of early September 2024, the stock has seen a modest increase of 2.47%. It has fluctuated between ₹0.93 and ₹0.54 in recent times.
The company’s book value is ₹0.81, and it has no dividend yield. Financially, Amerise Biosciences is facing challenges, as indicated by negative returns on capital employed (ROCE) and equity (ROE) at -2.73% and -2.75%, respectively.
| Metric | Value |
|---|---|
| Current Price | ₹0.83 |
| Market Capitalization | ₹5.48 Cr. |
| High/Low Price | ₹0.93 / ₹0.54 |
| Stock P/E | N/A |
| Book Value | ₹0.81 |
| Dividend Yield | 0.00% |
| Return on Capital Employed (ROCE) | -2.73% |
| Return on Equity (ROE) | -2.75% |
| Face Value | ₹1.00 |
Q1 Results
The company’s financial results show varying performance over the last few quarters, with notable changes in sales, expenses, and profits. Below are the quarterly results for December 2023, March 2024, and June 2024:
| Metric | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|
| Expenses (₹ Cr) | 0.06 | 0.02 | 0.05 |
| Operating Profit (₹ Cr) | -0.06 | -0.02 | -0.05 |
| OPM % | N/A | N/A | N/A |
| Other Income (₹ Cr) | 0.00 | 0.04 | 0.00 |
| Profit Before Tax (₹ Cr) | -0.06 | 0.02 | -0.05 |
| Net Profit (₹ Cr) | -0.06 | 0.02 | -0.05 |
| EPS (₹) | -0.01 | 0.00 | -0.01 |
About Amerise Biosciences
Amerise Biosciences, formerly known as Amradeep Industries, is a company that transitioned from manufacturing decorative boards and laminates to focusing on biosciences. Founded in 1984, the company was involved in trading and producing laminates in India and internationally.
However, due to financial difficulties and a lack of working capital, it became non-operational in recent years. In 2021, the company rebranded to Amerise Biosciences to reflect a shift in focus towards bioscience-related activities.
Check our website for more Q1 results.
Amerise Biosciences Q1 Results- FAQs
1. What is the net profit of Amerise Biosciences for Q1 2024-2025?
The net profit of Amerise Biosciences for Q1 2024-2025 was a loss of ₹4.87 lakhs.
2. When did Amerise Biosciences announce their Q1 results for 2024-2025?
Amerise Biosciences announced their Q1 results for 2024-2025 on 6 August 2024.
3. What was the revenue from operations for Amerise Biosciences in Q1 2024-2025?
The revenue from operations for Amerise Biosciences in Q1 2024-2025 was ₹3.58 lakhs.
4. How much were the total expenses for Amerise Biosciences in Q1 2024-2025?
The total expenses for Amerise Biosciences in Q1 2024-2025 were ₹4.87 lakhs.
5. What was the gross revenue from the sale of products for Amerise Biosciences in Q1 2024-2025?
The gross revenue from the sale of products for Amerise Biosciences in Q1 2024-2025 was ₹3.58 lakhs.
6. What was the basic earnings per share (EPS) for Amerise Biosciences in Q1 2024-2025?
The basic earnings per share (EPS) for Amerise Biosciences in Q1 2024-2025 was ₹(0.01).
7. What were the employee benefit expenses for Amerise Biosciences in Q1 2024-2025?
The employee benefit expenses for Amerise Biosciences in Q1 2024-2025 were ₹0.60 lakhs.
8. How much did Amerise Biosciences report as other expenses in Q1 2024-2025?
Amerise Biosciences reported ₹4.27 lakhs as other expenses in Q1 2024-2025.
9. What was the finance cost for Amerise Biosciences in Q1 2024-2025?
The finance cost for Amerise Biosciences in Q1 2024-2025 was ₹0.33 lakhs.
10. What is the other equity for Amerise Biosciences in Q1 2024-2025?
The other equity for Amerise Biosciences in Q1 2024-2025 was ₹660.69 lakhs.